---
title: "Mangoceuticals, Inc. (MGRX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MGRX.US.md"
symbol: "MGRX.US"
name: "Mangoceuticals, Inc."
industry: "Drug Retail"
datetime: "2026-05-20T09:39:08.148Z"
locales:
  - [en](https://longbridge.com/en/quote/MGRX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MGRX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MGRX.US.md)
---

# Mangoceuticals, Inc. (MGRX.US)

## Company Overview

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations.

| Item | Detail |
|------|--------|
| Industry | Drug Retail |
| Exchange | US Market |
| Website | [www.mangoceuticals.com](https://www.mangoceuticals.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: D (0.67)**

**Industry**: Drug Retail

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 5 |
| Industry Median | D |
| Industry Average | D |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -25.96% |  |
| Net Profit YoY | -129.47% |  |
| P/B Ratio | 0.46 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 7007544.46 |  |
| Revenue | 456021.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -149.72% | E |
| Profit Margin | -4526.76% | E |
| Gross Margin | 54.91% | B |
| Revenue YoY | -25.96% | E |
| Net Profit YoY | -129.47% | E |
| Total Assets YoY | 4.68% | C |
| Net Assets YoY | 8.99% | B |
| Cash Flow Margin | 26.81% | D |
| OCF YoY | -25.96% | E |
| Turnover | 0.03 | E |
| Gearing Ratio | 5.54% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Mangoceuticals, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-25.96%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-129.47%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.46",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "7007544.46",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "456021.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-149.72%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-4526.76%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "54.91%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-25.96%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-129.47%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "4.68%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "8.99%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "26.81%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-25.96%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.03",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "5.54%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.32 | 3/5 | - | - | - |
| PB | 0.46 | 2/5 | 1.18 | 0.90 | 0.42 |
| PS (TTM) | 15.37 | 4/5 | 45.33 | 33.66 | 14.09 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Ridgetech (RDGT.US) | D | D | A | C | D | C |
| 02 | 111 Inc. (YI.US) | C | D | A | E | E | D |
| 03 | Mangoceuticals (MGRX.US) | E | D | E | A | D | D |
| 04 | Walgreens Boots Alliance (WBA.US) | E | C | A | E | D | D |
| 05 | China Jo Jo Drugstores (CJJD.US) | D | C | A | E | E | D |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MGRX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MGRX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MGRX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MGRX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**